Peptide Deamidation: Finding the 0.98 Da Shift in Stored Lots
Of all the ways a stored peptide can change, peptide deamidation is among the most frequent and the easiest to overlook. It swaps a side-chain amide for a carboxylic acid, adds less than one dalton to the molecular mass, and can sit almost exactly under the parent peak on a routine chromatogram. For labs holding a large stock of vials from one lot, it is also a reminder that the chemistry does not stop once a certificate is issued. This guide covers the reaction, the sequence features that speed it up, and how it shows up on analytical data.
The chemistry in one paragraph
Asparagine (Asn) and, more slowly, glutamine (Gln) carry an amide group on their side chains. Under the right conditions, the backbone nitrogen of the next residue attacks that side-chain carbonyl and releases ammonia, forming a five-membered succinimide ring. Water then opens the ring. Depending on which bond breaks, the product is either ordinary aspartate (Asp) or isoaspartate (isoAsp), in which the backbone now runs through what used to be the side chain. In most studies isoaspartate is the larger share. The net change from the original asparagine is loss of NH and gain of O, a mass increase of about 0.984 Da.
Why peptide deamidation depends on sequence
The rate is set largely by the residue that follows the asparagine, because that neighbour’s backbone nitrogen must swing round to form the ring. Small, flexible neighbours make this easy; bulky ones get in the way.
| Motif | Relative tendency | Reason |
|---|---|---|
| Asn-Gly | Fastest | Glycine has no side chain to block ring closure |
| Asn-Ser, Asn-Ala, Asn-His | Intermediate | Small or helpful side chains allow reasonable access |
| Asn followed by bulky residues (Val, Ile, Leu) | Slow | Steric hindrance slows ring formation |
| Gln in most contexts | Much slower than Asn | Would need a less favourable six-membered ring |
Local structure matters too. In a short, flexible research peptide, the backbone can adopt the needed geometry easily, so the sequence motif dominates. The practical upshot for a lab is that stability data for one peptide rarely transfers to another, even one of similar length, if their Asn neighbours differ.
Conditions that accelerate it
- Water: ring opening needs it, and so does mobility. A dry lyophilised solid deamidates far more slowly than the same peptide in solution, which is one reason bulk stock is held as a dry powder.
- pH: neutral to mildly alkaline conditions favour succinimide formation. Under strongly acidic conditions, direct hydrolysis of the amide can occur instead, and that route yields Asp only.
- Temperature: like most degradation reactions, it speeds up as temperature rises.
- Buffer choice: some buffer species, phosphate among them, are reported to accelerate the reaction compared with others at the same pH.
For analytical solutions prepared for HPLC or in-vitro assays, the clock effectively starts when the solid meets solvent. Keeping working solutions cold, using them promptly and avoiding unnecessary time at neutral or basic pH all slow the process.
Spotting the 0.984 Da shift on a mass spectrum
Here is the subtle part. Every peptide already shows an isotope pattern: a monoisotopic peak followed by a second peak about 1.003 Da higher, mainly from carbon-13. A deamidated species adds 0.984 Da, which lands just 0.019 Da below that natural isotope peak. On a low-resolution instrument the two merge, and deamidation shows up only as a distorted isotope ratio: the second peak looks taller than it should.
High-resolution mass spectrometry can separate the two, or the lab can compare the measured isotope distribution with the theoretical one. Either way, the full isotope cluster is more informative than a single labelled mass.
Telling Asp from isoAsp
Asp and isoAsp products have identical mass, so intact-mass measurement cannot distinguish them. Separation is possible by chromatography, since isoAsp forms often elute slightly differently, and specialised techniques such as certain fragmentation modes in tandem mass spectrometry or enzyme-based isoAsp assays can identify them specifically. These are research-level tools rather than routine certificate tests.
What the chromatogram shows
Deamidation adds a negative charge at neutral pH, and changes the peptide’s polarity. On reversed-phase HPLC the deamidated species often appears as a small peak or shoulder next to the main peak, though it can overlap heavily depending on conditions. Measured at around 214 nm, where the peptide backbone dominates, it is counted as an impurity in the area percentage. At longer wavelengths the result depends on the aromatic content of the sequence.
A lot can therefore pass release testing with a low level of deamidated material, then show a gradually growing shoulder in re-tests after long or warm storage. That is not a contradiction; it is the reaction proceeding.
Managing it across a large stock
For labs holding many vials from one lot over months:
- Keep unopened vials dry, sealed and cold, and avoid repeated warming and cooling of the whole stock.
- Let vials reach room temperature before opening, so condensation does not wet the solid.
- Log receipt date, storage location and any temperature excursions against the lot number.
- If a sequence contains an Asn-Gly or Asn-Ser motif, consider scheduling a re-test of a retained vial before starting a long series of experiments.
Our products are third-party tested for HPLC purity, and certificates are available for a number of them. The cap and crimp colour on each vial shows which certificate it corresponds to, which helps when older and newer lots share a shelf.
What a deamidation finding does not tell you
A deamidated peak confirms that the chemical change occurred. On its own it does not reveal when it happened (during synthesis, purification or storage), and it does not quantify the fraction affected unless the chromatogram was integrated for that species. It also has no bearing on sterility or endotoxin.
Bulk Peptides provides these compounds solely for in-vitro and analytical research. They are not intended for any human or animal use.

